Drug intelligence / Profile preview

periciazine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Periciazine is a first-generation antipsychotic of the phenothiazine class, specifically a piperidine phenothiazine derivative. It is primarily used for the management of schizophrenia and other psychoses, as well as for short-term adjunctive treatment of severe anxiety, psychomotor agitation, and violent or dangerously impulsive behavior. Periciazine acts mainly by antagonizing central dopamine receptors (notably D1) and adrenoceptors (including alpha-1B and alpha-2A adrenergic receptors), leading to its antipsychotic, sedative, adrenolytic, anticholinergic, metabolic, and endocrine effects. Its mechanism involves central adrenergic blockade in subcortical brain regions[1][2][6][8]. The drug has weak antipsychotic properties compared to other typical antipsychotics but is effective in reducing pathologic arousal and affective tension[1][2].

Brand names
NeulactilNeuleptil
Other names
pericyazinepropericiazine
02

Targets

ADRA2A (α2A)DRD1 (Dopamine D1 Receptor)ADRA1B (α1B)

Beyond the preview

Go deeper on periciazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on periciazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call